Corrigendum: Endothelial-immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease (EMBO Reports, (2022), 23, e54271, 10.15252/embr.202154271)

A co-author was omitted from the original publication. Walter Wahli contributed to developing the LIDPAD mouse model, which was required for the data in Fig. 3F. The authors apologise for this oversight and any confusion it may have caused. Walter Wahli is herewith added as an author with the following affiliations: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Institut National de Recherche pour L’agriculture, l’alimentation et l’environnement (INRAE), Toxalim (Research Centre in Food Toxicology), 180 Chemin de Tournefeuille, 1,331 Toulouse, France. Center for Integrative Genomics, Université de Lausanne, Le Génopode, 1,015 Lausanne, Switzerland. The following sections have been amended to include author-specific information: Author contributions Walter Wahli contributed to the resources and supervision. Acknowledgements “The development of the LIDPAD model was supported by NTUitive SPARK programme (WW), Ferring Singapore Innovation grant (WW, NS) and Lee Kong Chian School of Medicine, Nanyang Technological University Singapore Start-Up Grant (WW).” Diet-induced NAFLD murine models The authors are including the sentence, “The mice were kept at thermoneutral zone temperature of 30°C during the diet induction.” Lastly, two references to an unpublished paper have been removed, as the mouse model referenced is already sufficiently described in this publication, and with this corrigendum, the corresponding author of the unpublished paper has been added as a co-author of this paper. The following sentence has been removed. “The manuscript (Low et al, data not published) relating to this novel LIDPAD diet-induced NAFLD model is in submission elsewhere.” The following sentence has been modified from “In addition, an improved diet-inducible liver disease mouse model was established by the use of a modified Liver Disease Progression Aggravation Diet (LIDPAD; Low et al manuscript in submission elsewhere).” to “In addition, an improved diet-inducible liver disease mouse model was established by the use of a modified Liver Disease Progression Aggravation Diet (LIDPAD).”